Los Angeles Capital Management LLC Myriad Genetics Inc Transaction History

Los Angeles Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 07, 2019	SELL	$22.08 - $47.08 $878,850 - $1.87 Million	-39,803 Closed	0 $0
Q2 2019 Jul 29, 2019	SELL	$22.67 - $35.0 $425,515 - $656,950	-18,770 Reduced 32.05%	39,803 $1.11 Million
Q1 2019 Apr 25, 2019	SELL	$26.93 - $34.7 $196,050 - $252,616	-7,280 Reduced 11.05%	58,573 $1.95 Million
Q4 2018 Feb 11, 2019	BUY	$27.23 - $45.56 $175,497 - $293,634	6,445 Added 10.85%	65,853 $1.91 Million
Q3 2018 Nov 05, 2018	BUY	$37.57 - $50.34 $1.57 Million - $2.11 Million	41,908 Added 239.47%	59,408 $2.73 Million
Q2 2018 Jul 31, 2018	SELL	$27.75 - $40.17 $232,822 - $337,026	-8,390 Reduced 32.41%	17,500 $654,000
Q1 2018 Apr 27, 2018	BUY	$28.83 - $41.01 $578,041 - $822,250	20,050 Added 343.32%	25,890 $765,000
Q4 2017 Feb 05, 2018	BUY	$28.45 - $37.14 $166,148 - $216,897	5,840	5,840 $201,000

254

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.3B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.